secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2025-09-30T23:59:59+00:00
Accession:  0001493152-25-016366
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity closes $4.8M public offering; Nasdaq compliance extension received
------------------------------------------------------------------------------

- Gross proceeds of $4.8M from sale of 1,921,761 shares/pre-funded warrants at $2.50/$2.493 per unit.
- After closing and warrant exercises, common shares outstanding total 3,100,402.
- 1-for-30 reverse stock split effective Sept 19; eliminated ~$4M in derivative liabilities.
- Company believes it regained compliance with Nasdaq minimum bid price and equity requirements; extension granted to Oct 2.
- Warrant amendments and exercises contributed ~$2.8M equity and ~$1.3M cash.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315225016366/0001493152-25-016366-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315225016366/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-016366

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer